[1]
2009. Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer. Swiss Medical Weekly. 139, 1516 (Apr. 2009), 220–220. DOI:https://doi.org/10.4414/smw.2009.12284.